Dr. Robert Murphy: Why the Moderna booster hasn’t been approved by the FDA


FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck is buying Acceleron Pharma in a deal worth about $11.5 billion. Merck said Thursday, Sept. 30, 2021, that it will pay $180 per share in cash for each Acceleron share. (AP Photo/Seth Wenig, File)

Dr. Robert Murphy of Northwestern Feinberg School of Medicine joins Lisa Dent to explain why the Moderna booster shot hasn’t been approved, and to elaborate on the three drugs that will treat COVID.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

COVID-19 risk as determined by nonprofit Covid Act Now.

Coronavirus Resources from the CDC

The Mincing Rascals

More The Mincing Rascals

The John Williams Show
Weekdays 9 a.m. - noon JohnWilliams

Focusing on current events, John discusses the news of the day, sports, television programs, movies, and books with a thoughtful perspective and quirky sense of humor. Inquisitive and curious by nature, he asks what listeners want to know and his guests never get a pass on the tough questions. (Click for more.)

The John Williams NewsClick sponsored by Joint Relief Institute

More NewsClick